The standard assumption about placebos is that the trick only works if the patient doesn’t know it’s a trick. Hand someone a sugar pill and tell them it’s a real medication, and their symptoms might ease up. Tell them the truth, that the pill does nothing, and the thinking goes that the effect should collapse along with the illusion. A patient can’t talk themselves into feeling better from a treatment they know is fake.
A 2010 clinical trial tested that assumption directly, on real patients with a real condition rather than healthy volunteers imagining a symptom, and the results didn’t match it at all.
What the study actually did
Researchers led by Ted Kaptchuk at Harvard Medical School and Beth Israel Deaconess Medical Center recruited 80 patients with irritable bowel syndrome, a condition with no reliable cure and symptoms that are known to respond, at least somewhat, to placebo treatment in ordinary drug trials. The patients were split into two groups. One group received no pill of any kind, just the same quality of attention and interaction with their provider as everyone else.
The other group was handed a bottle explicitly labeled “placebo pills,” and told directly, in plain language, that the pills were “made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes.” Nobody was misled about what was in the bottle. The label said placebo, and the researchers said placebo, out loud, before a single pill was swallowed.
By the researchers’ own account going in, “it is widely believed that response to placebo requires concealment or deception.” This study existed specifically to test whether that belief held up, and the design was deliberately simple: two groups, the same amount of attention from a provider, with the only real difference being a bottle of pills that did nothing and a label that said so.
Why the common assumption turned out to be wrong
It didn’t hold up. Patients taking the openly labeled placebo reported significantly greater improvement than the no-treatment group, on a scale measuring overall symptom relief, at both the 11-day mark and the 21-day end of the three-week trial. By the end of the study, 59 percent of the openly-informed placebo group reported adequate relief from their symptoms, compared with 35 percent of the group that received nothing. The researchers’ own conclusion was direct: “placebos administered without deception may be an effective treatment for IBS.”
That finding has since been tested well beyond one condition and one research team. A 2021 meta-analysis pooling 11 separate trials of open-label placebo, covering different conditions and different research groups, found a real overall effect compared to no treatment. The same review was honest about the limits of what’s known so far: the researchers themselves described the evidence as still in its early stages, with effect sizes that shrank somewhat once lower-quality studies were excluded, and most outcomes measured through what patients reported rather than an objective physical test.
What might actually be happening instead
If deception isn’t the active ingredient, something else has to be doing the work. Researchers who study this point to a handful of overlapping possibilities: the ritual of taking a pill on a schedule, twice a day, is itself a behavior the body has learned to associate with getting better, built up over a lifetime of taking medications that actually did something. A caring explanation from a provider, of the kind both groups in the Kaptchuk trial received, has measurable effects on symptoms on its own, independent of what’s in the bottle.
And simply being told that a treatment has helped other people with the same condition, even an inert one, seems to be enough to shift how a person’s body responds, without requiring the person to be fooled about what they’re taking. Some researchers in this area point to a kind of learned response built up over years of taking pills that did work, the body picking up a pattern that a capsule swallowed on schedule tends to precede feeling better, a pattern strong enough that it can fire even once someone knows this particular capsule has nothing active inside it.
What this doesn’t mean for someone managing a real condition
It’s worth being direct about the limits here, since this involves medical treatment and not just an interesting psychology finding: this is not medical advice, and nothing here is a suggestion to swap out a prescribed medication for sugar pills, open-label or otherwise. Irritable bowel syndrome and the conditions studied alongside it are not stand-ins for every illness, and a treatment that helps with subjective symptom scores in a research setting is a long way from a treatment that can be trusted to manage something dangerous left untreated. Researchers in this field are studying open-label placebo as a possible add-on to standard care, delivered and monitored by a doctor, not as a replacement for it or a do-it-yourself alternative to seeing one. Anyone considering it for a real condition should be raising it with their own doctor, not assembling a version of it at home based on an article.
What the research does suggest is narrower and, in its own way, more useful: a person’s expectation of getting better, and the ritual of a treatment, appear to carry real weight even when there’s no secret involved. That’s a reason to take the relationship between a patient and a provider seriously as part of medical care in its own right, not a reason to skip the provider and keep a bottle of sugar pills in the medicine cabinet instead. The pill in Kaptchuk’s trial wasn’t doing the work alone. It was doing it alongside a doctor’s attention, a clear explanation, and a patient who chose, with full knowledge, to take part.
